• FDA commissioner: Medical misinformation is hurting US life expectancy

    Medical misinformation is a contributing factor to lowered life expectancies in the U.S., FDA Commissioner Robert Califf, MD, told CNBC.
  • The new 'Operation Warp Speed'

    The Biden administration aims to accelerate the development of new coronavirus vaccines and treatments through a more than $5 billion program dubbed "Project Next Gen," The Washington Post reported April 10.
  • Fungus infects dozens, hospitalizes 12 at Michigan factory

    Blastomycosis, a fungus found in soil and decaying wood, is believed to have infected more than 90 employees at a paper mill in Escanaba, Mich., according to an April 8 report from the Detroit Free Press.
  • XBB subvariants to crowd out dominant US strain: 3 COVID-19 updates

    Omicron subvariant XBB.1.15 has remained dominant since January, but several other XBB offshoots may crowd out the strain over the next few weeks. 
  • 4 ways avian flu must evolve to become a human pandemic

    An outbreak of avian flu at a Spanish mink farm in October 2022 and several other reported cases of the virus's spread to mammals sparked concern of its transmission to humans. But experts say it will take a lot for avian flu to become a full-fledged human pandemic, Science reported.
  • 11 notes on the new omicron subvariant

    A new SARS-CoV-2 omicron subvariant, XBB.1.16, is spreading throughout several countries, including parts of the U.S. Health officials at the World Health Organization have said it is something they are closely monitoring. 
  • CDC warns clinicians about risks of imported cases of Marburg

    The CDC issued a health advisory April 6 alerting clinicians in the U.S. to be aware of two Marburg virus disease outbreaks currently happening overseas — though at this time no cases have been confirmed in the U.S.
  • 8 things WHO should add to its to-do list, per health experts

    The World Health Organization turns 75 on April 7. While it finalizes its updated list of pandemic pathogens — which is set to be released any day — here are a few things health experts told NPR it should add to its agenda in 2023.
  • COVID-19 hospitalizations up in 16 states 1 month out from end of PHE

    Nearly one month out from the end of the public health emergency in the U.S., hospitalizations are on the rise in 16 different states, and a new omicron subvariant has been spotted in 18 states. 
  • Solidifying long COVID-19's definition is key, researchers say

    While some aspects of long COVID-19 — sometimes referred to as post-COVID-19 condition, or PCC — are much better understood than before, researchers have yet to land on a unified definition for the condition.
  • Infertility is a challenge for 1 in 6: WHO

    Roughly 17.5 percent of adults worldwide experience infertility issues, a new report from the World Health Organization has found.
  • Influenza B cases tick up: 3 notes

    Overall, flu activity in the U.S. remains low and is down significantly from the late fall peak. However, the percentage of specimens testing positive for influenza B has risen in recent weeks. 
  • Researchers question NIH's long COVID study with exercise trials

    Researchers and international organizations are probing for more information on long COVID studies run by the National Institutes of Health because of exercise measurements, Nature reported March 31. 
  • Fentanyl and 'Tranq' mixtures are a 'deadly' combination on the rise

    Widespread mixtures of fentanyl and xylazine are causing concern for health officials in South Dakota — particularly because the combination cannot be aided by naloxone, according to an April 4 news release from the state's department of health.
  • US plans $300M database for Alzheimer's research

    The federal government plans to build a massive Alzheimer's research database capable of tracking the long-term health of up to 90 percent of the population, according to an exclusive April 3 report from Reuters. 
  • Nevada and California lead nation in number of C. auris cases

    Candida auris infections are increasingly on the rise across the U.S. — something the CDC has cited as "an emerging fungus that presents a serious global health threat." Now, the fungus has induced infections across dozens of states.
  • FDA to clear another booster for high-risk groups, officials say

    The FDA is planning to make another COVID-19 booster that targets omicron available for high-risk individuals, The Washington Post reported April 3.
  • Hackensack Meridian Health awarded $477K in grants for medical research, community health projects 

    The New Jersey Health Foundation awarded Edison, N.J.-based Hackensack Meridian Health almost $477,000 in grants, according to an April 3 HMH press release. The grants will be used to support research efforts and community health projects throughout New Jersey.
  • Coronavirus variant XBB.1.16 spotted in 18 US states

    The new SARS-CoV-2 omicron variant XBB.1.16 has spurred increased hospitalizations and deaths in some countries. In the U.S., the dominant variant is still XBB.1.5, but health officials say other variants are on the rise.
  • Concerns grow over drug-resistant bacteria tied to eye infections

    Pseudomonas aeruginosa, the strain of drug-resistant bacteria that has been found in eye drops and ointment imported from India, has never been found before in the U.S., the CDC said. 

Featured Whitepapers

Featured Webinars

>